6,7-DIFLUORO-5-NITRO-1H-INDAZOL-3-AMINE, 95.0%, 250mg

(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, 98%, 1g

3-BROMO-7-METHYL-2-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 1g

L-tert-Leucine methyl ester hydrochloride, 97.0%, 500g

5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione, 99%, 5g

(E)-3-Benzylidenedihydrofuran-2(3H)-one, 97%, 250mg

[cis-3-methoxycyclobutyl]methanamine hydrochloride, 97.0%, 500mg

Solución estándar multielemento A para ICP, ROTI®Star, 100 ml, HDPE

2-Methyl-3-(4-nitro-pyrazol-1-yl)-propionic acid methyl ester, 98%, 5g

2-Hydroxyheptanoic acid, 95%, 100mg

N-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine, 95.0%, 1g

Ethyl 2-oxo-1,2-dihydropyridine-4-carboxylate, 95.0%, 1g

1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 5g